Their mechanism of action involves NLRP3 inflammasome activation, dendritic cell recruitment, and cytokine production (IFN-γ, IL-1β) and can be particularly valuable for adjuvant vaccines to diseases requiring strong cellular immunity (e.g., malaria, tuberculosis, HIV). The gene discussed is IL1B; the disease is tuberculosis.